Metabolism through the cytochrome P450 is altered in cancer, and there is large inter-individual variability in CYP3A activity in patients with cancer63, further complicating attempts to predict the potential clinical impact of specific drug–drug interactions. Here, CYP3A4 is linked to cancer.